| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1700170 | 重组人源化抗人IL-6R单克隆抗体注射液 | Injection | Biological Products(2) | New Drug Application | 2018-02-08 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2018-10-29 | view |